Comparing genomic profiles of tumour and peritumoral biopsies to find new possible biomarkers for glioblastoma therapy.

Authors

  • Martina Giambra Milan-Bicocca University, Monza e Brianza
  • Eleonora Messuti Milan-Bicocca University, Monza e Brianza
  • Serena Redaelli Milan-Bicocca University, Monza e Brianza
  • Andrea Di Cristofori San Gerardo Hospital, Monza e Brianza
  • Angela Bentivegna Milan-Bicocca University, Monza e Brianza

DOI:

https://doi.org/10.4081/bse.170

Keywords:

GBM, GSC, PBZ, CAN, array-CGH

Abstract

The study of glioblastoma genomic profiles permits the use of CNAs load to identify patients with poor prognosis and the understanding of the genomic signatures essential for the disease maintenance and the identification of new potential biomarkers.

Downloads

Download data is not yet available.

References

Downloads

Published

29-09-2021

Issue

Vol. 2 No. 1 (2021)

Section

Communications

License

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.

How to Cite

Comparing genomic profiles of tumour and peritumoral biopsies to find new possible biomarkers for glioblastoma therapy. (2021). Biomedical Science and Engineering, 2(1). https://doi.org/10.4081/bse.170